Treatment of hyperglycaemia in type 3c diabetes is not clearly differentiated from that for type 1 and type 2 diabetes,6 with current recommendations limited to considering early insulin initiation and avoidance of incretin‐based therapies due to their potential association with pancreatitis.12 The gene discussed is INS; the disease is type 2 diabetes mellitus.